The group posted a strong improvement in performance against challenging market conditions in industrial and life science markets, but buoyed by contributions from acquisitions and robust demand in the Aerospace and Defence (A&D) markets. The order book has significantly increased on the back of robust A&D orders, with the group order book up 36% at the year end with momentum continuing into the current FY26. The outlook points to being on track to meet FY26 expectations and we make no change to ....
